ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1948

Evaluation of Body Composition Parameters in Granulomatosis with Polyangiitis: Association of Fat Mass Parameters with Disease Activity and Inflammatory Markers

Mariana O Perez1, Valeria F Caparbo2, Mauricio Levy-Neto2 and Rosa M R Pereira2, 1Rheumatology Divison, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: adipose tissue, body mass and inflammation, Disease Activity, Wegener's granulomatosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Vasculitis - Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Granulomatosis with polyangiitis (GPA, Wegener´s) patients are more exposed to traditional cardiovascular risk factor, including obesity. In rheumatic diseases, inflammation has been associated with abnormal body composition (BC). Visceral adipose tissue (VAT) is a metabolically active tissue and is a source of humoral and cellular inflammation. It has been demonstrated that VAT is associated with incidence metabolic risk beyond its contribution to overall adiposity. Therefore, the objective of this study is to compare BC parameters, with emphasis in body fat and VAT, in GPA patients versus healthy controls and to explore the association of these parameters with disease activity and inflammatory markers.

Methods:  This cross-sectional study was conducted in 32 GPA patients and 32 healthy controls matched by sex, age and body mass index (BMI). Disease activity was assessed by Birmingham Vasculitis Activity Score (BVAS) and ANCA. Damage was assessed by Vasculitis Damage Index (VDI). C-reactive protein (CRP, normal: < 5mg/L) and Erythrocyte sedimentation rate (ESR, normal < 15mm/1st hour for men and < 20mm/1st hour for women) were measured. BC was analyzed using dual-energy X-ray absorptiometry (DXA). Fat mass parameters evaluated were: total fat mass (FM), adiposity (percentage of body fat), fat mass index (FMI: fat mass/ht2) and VAT (g, cm3, cm2).

Results:  Compared GPA patients with healthy controls, a significantly greater VAT (696.00 ± 284.96 vs. 574.34 ± 243.82 g, p=0.03; 752.34 ± 313.01 vs. 621 ± 263.60 cm3, p=0.03 and 144.34 ± 60.02 vs. 119.11 ± 50.54 cm2, p=0.03) were observed in patients. GPA patients with BVAS > 1 demonstrated higher adiposity (38.71 ± 12.16 vs. 31.47 ± 9.29%, p=0.04) and FMI (13.78 ± 6.43 vs. 9.66 ± 4.39 Kg/m2, p=0.02), compared to patients with BVAS ≤ 1. ANCA and VDI were not associated with any fat mass parameters. Elevated CRP and ESR were observed in GPA patients with higher FMI (13.54 ± 6.45 vs. 9.72 ± 4.45 Kg/m2 p=0.04 and 13.68 ± 6.81 vs. 9.68 ± 4.27 Kg/m2 p=0.03, respectively). No correlation was observed between fat mass parameters (FM, adiposity, FMI and VAT) and prednisone cumulative dose (p>0.05).

Conclusion:  Our data suggest that GPA patients have abnormal BC, mainly in fat mass parameters and these variables are associated with inflammation and disease activity suggesting that BC should be evaluated in GPA patients to understand and prevent comorbidities in these subjects.


Disclosure: M. O. Perez, None; V. F. Caparbo, None; M. Levy-Neto, None; R. M. R. Pereira, None.

To cite this abstract in AMA style:

Perez MO, Caparbo VF, Levy-Neto M, Pereira RMR. Evaluation of Body Composition Parameters in Granulomatosis with Polyangiitis: Association of Fat Mass Parameters with Disease Activity and Inflammatory Markers [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/evaluation-of-body-composition-parameters-in-granulomatosis-with-polyangiitis-association-of-fat-mass-parameters-with-disease-activity-and-inflammatory-markers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-body-composition-parameters-in-granulomatosis-with-polyangiitis-association-of-fat-mass-parameters-with-disease-activity-and-inflammatory-markers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology